Frequency distribution of the A91V and N252S PRF1 variations and the OPNhigh genotypes in 14 ALPS and 28 DALD patients
. | ALPS* . | . | DALD† . | . | Controls . | . | |||
---|---|---|---|---|---|---|---|---|---|
Genotypes according to variation . | N . | % . | N . | % . | N . | % . | |||
PRF1 N252S | |||||||||
NN | 12 | 85.7 | 28 | 100 | 814 | 99.8 | |||
NS | 2 | 14.3 | 0 | 0 | 2 | 0.2 | |||
SS | 0 | 0 | 0 | 0 | 0 | 0 | |||
PRF1 A91V | |||||||||
AA | 14 | 100 | 22 | 78.5 | 744 | 91.2 | |||
AV | 0 | 0 | 5 | 17.9 | 69 | 8.4 | |||
VV | 0 | 0 | 1 | 3.6 | 3 | 0.4 | |||
PRF1 and OPN susceptibility genotypes‡ | |||||||||
None | 4 | 28.6 | 6 | 21.4 | 51 | 38.1 | |||
PRF1 alone | 2 | 14.3 | 0 | 0 | 10 | 7.5 | |||
OPN alone | 8 | 57.1 | 16 | 57.2 | 70 | 52.2 | |||
PRF1 + OPN | 0 | 0 | 6 | 21.4 | 3 | 2.2 |
. | ALPS* . | . | DALD† . | . | Controls . | . | |||
---|---|---|---|---|---|---|---|---|---|
Genotypes according to variation . | N . | % . | N . | % . | N . | % . | |||
PRF1 N252S | |||||||||
NN | 12 | 85.7 | 28 | 100 | 814 | 99.8 | |||
NS | 2 | 14.3 | 0 | 0 | 2 | 0.2 | |||
SS | 0 | 0 | 0 | 0 | 0 | 0 | |||
PRF1 A91V | |||||||||
AA | 14 | 100 | 22 | 78.5 | 744 | 91.2 | |||
AV | 0 | 0 | 5 | 17.9 | 69 | 8.4 | |||
VV | 0 | 0 | 1 | 3.6 | 3 | 0.4 | |||
PRF1 and OPN susceptibility genotypes‡ | |||||||||
None | 4 | 28.6 | 6 | 21.4 | 51 | 38.1 | |||
PRF1 alone | 2 | 14.3 | 0 | 0 | 10 | 7.5 | |||
OPN alone | 8 | 57.1 | 16 | 57.2 | 70 | 52.2 | |||
PRF1 + OPN | 0 | 0 | 6 | 21.4 | 3 | 2.2 |
The overall genotypic distribution of N252S was significantly different from controls (P = .0016, Fisher exact test).
The overall genotypic distribution of A91V was significantly different from controls (P = .01, Chi square test); frequency of PRF1+OPN susceptibility genotypes was significantly higher than in controls (P = .0009, Fisher exact test).
Genotypes with the N252S (in ALPS) or A91V (in DALD) PRF1 variations (either homozygous or heterozygous) and/or the 282C-750T-1083A-1239C or 282C-750T-1083G-1239C OPNhigh haplotypes.